Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neoplasm, Residual × Vitamin D × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm, Residual 1 Multiple Myeloma 1 Leiomyoma 1 Giant Cell Tumor of Bone 1 Disease Progression 1

Interventions

blinatumomab 5 midostaurin 2 Azacitidine 2 venetoclax 1 tisagenlecleucel 1 siremadlin 1 sabatolimab 1 pulrodemstat besilate 1 posaconazole 1 fludarabine phosphate 1 fludarabine 1 Zoledronic Acid 1 Vitamin D 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Midazolam 1 Idarubicin 1 Drug Therapy 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Calcium 1 CD3 Complex 1 Anthracyclines 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00172068 2009-12-23

MRD-1

Novartis

Phase 2 Terminated

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡